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This report describes a 40-year old man with a history of acquired immunodeﬁciency syndrome (AIDS)
diagnosed with Pneumocystis jiroveci pneumonia (PJP) twice prior to this admission, who presented with
3 days of fever, non-productive cough and shortness of breath. The patient was treated empirically for
PJP, but his condition deteriorated rapidly and he expired despite resuscitative efforts. The bron-
choalveolar lavage (BAL) and blood cultures grew Cryptococcus neoformans. Very few cases of dissemi-
nated cryptococcosis presenting as acute respiratory failure have been reported. Cryptococcosis is
a common opportunistic infection that should be considered in patients with AIDS presenting with
bilateral pulmonary inﬁltrates and fever.
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rved.1. Case report
A 40-year old man was admitted to the hospital with 3 days of
fever, non-productive cough and shortness of breath. The patient
denied headache or blurry vision. He had AIDS and his last CD4
count was twelve. He was not on anti-retroviral therapy because of
non-compliance. 18 and 4 months prior to admission he had Pneu-
mocystis jiroveci pneumonia (PJP) diagnosed by bronchoalveolar
lavage (BAL); both episodes were treated with trimethoprim-
sulfamethoxazole (TMP-SMZ) and prednisone. One week after his
last discharge hewas readmittedwith agranulocytosis secondary to
TMP-SMZ, which was discontinued, and he was switched to pri-
maquine and clindamycin. Unfortunately, he was non-compliant
with this regimen.
Examination on admission revealed blood pressure (BP) 116/89,
heart rate 111 beats per minute, temperature 36.9

C, respiratory
rate 26, transcutaneous oxygen saturation 91% on room air and 94%
on 4-L/min oxygen via nasal cannula. There was no jugular venous
distention, lymphadenopathy, cyanosis, clubbing, pallor or icterus.
Bibasilar coarse crackles were heard on chest exam. Cardiac exam
was unremarkable except for tachycardia. The abdomen was soft
with no organomegaly. Neurologic exam was unremarkable.
Laboratory ﬁndings included white blood cell count 3.7  109/L,
hemoglobin 17 g/dL, platelets 276  109/L. BUN was 33 mg/dL
creatinine 1.7 mg/dL (baseline 1.1 mg/dL), sodium 133 mmol/L,
potassium 5 mmol/L, chloride 97 mmol/L, bicarbonate 19 mmol/L,
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showed pH 7.38, PaCO2 26 mmHg, PaO2 94 mmHg. EKG revealed
sinus tachycardia at rate of 111. Chest X ray (CXR) is shown below.
He was treated for presumed PJP with clindamycin, primaquine
and prednisone. Over the next 24e36 h, he became more tachyp-
neic with increasing oxygen requirements. He remained hypoxic
despite receiving oxygen delivered through a non-rebreather mask.
A repeat CXR was unchanged. Hewas intubated and ventilated, and
a BALwas performed. Themetabolic acidosis worsened and he died
despite resuscitative attempts.
Culture of BAL ﬂuid grew Cryptococcus neoformans. No PJP was
identiﬁed in the BAL. Subsequently, the previously collected blood
cultures also grew C. neoformans.2. Discussion
Despite the advent of anti-retroviral therapy, PJP remains one of
the most common opportunistic AIDS-related pulmonary infec-
tions. Although some controversies exist regarding diagnosis and
management of PJP, experience and data now support empiric
treatment of PJP in a subset of carefully selected patients, with BAL
performed in case of clinical deterioration or failure to show
improvement within 4e5 days. The typical radiological features of
PJP are bilateral, symmetrical pulmonary inﬁltrates emanating from
the hilar regions. However, while empirically treating PJP it is
important to realize that the radiological presentation can be
mimicked by other opportunistic infections including cryptococ-
cosis, tuberculosis, and non-infectious diseases including intersti-
tial pneumonia, lymphoma, Kaposi sarcoma, and alveolar
hemorrhage. Coinfection with PJP and C. neoformans has been
demonstrated by various studies in up to 30% of autopsies per-
formed in HIV-infected patients. Our patient fulﬁlled the CDC
criteria for presumptive diagnosis of PJP and was initially managed
empirically, but had a deteriorating course with a postmortem
diagnosis of disseminated cryptococcosis.
Cryptococcosis, a possibly under-diagnosed opportunistic
infection in AIDS patients, is caused by an encapsulated yeast, C.
neoformans, commonly acquired from inhalation of the pathogen,
though in some cases skin has also been shown to be a portal of
entry. It is postulated that the organism can remain dormant in the
lungs or the central nervous system and that cryptococcosis in AIDS
patients represents reactivation of a latent infection. The most
frequent manifestation of cryptococcosis in an AIDS patient is
subacute meningitis or meningoencephalitis, generally with a CD4
count less than 100. Pulmonary cryptococcosis is asymptomatic in
up to one third of non-HIV patients whereas most HIV positive
patients are symptomatic with non-speciﬁc symptoms. The most
common symptom associated with pulmonary cryptococcsis in an
HIV positive patient is cough in 71e94%; other symptoms include
dyspnea, fever, weight loss, headache chest pain, and hemoptysis.1
Dissemination is deﬁned as isolation of Cryptococcus from an
extrapulmonary site such as blood or cerebrospinal ﬂuid. Central
nervous system (CNS) involvement is seen at the time of diagnosis
of pulmonary cryptococcosis in 22e92% of cases.1 A recent study
seeking to identify markers of disseminated infection in pulmonary
cryptococcosis found fever, interstitial pulmonary abnormalities
and pleural effusions more frequently associated with dissemi-
nated disease and highest titers of serum cryptococcal antigen.2
Disseminated cryptococcosis presenting as acute respiratory
failure (as in our case) is an uncommon presentation and has been
describedmainly in a few reports. In the largest reported case series
of patients with AIDS and cryptococcal disease, acute respiratory
failure occurred in 13.8% (29/210) of cases, with a 48 h mortality of
100%. Elevated LDH levels, interstitial pulmonary inﬁltrates andcutaneous lesions suggested disseminated disease in this group of
patients.3
Diagnosis of cryptococcosis is made by isolation of Cryptococcus
from a sterile body site, by histopathologic analysis, or by detection
of cryptococcal capsular antigen (CrAg). Serum CrAg (sCrAg) is
a rapid and reliable method of diagnosing cryptococcal infection,
with sensitivity and speciﬁcity between 93 and 100% depending on
the kit used.4 In AIDS patients localized pulmonary cryptococcosis is
generally associated with a negative sCrAg, hence its presence in
serum especially in high titers may be an indicator of dissemination
and should prompt further evaluation by means of a lumbar punc-
ture to look for CNS invasion. As stated previously, chest radio-
graphicﬁndings inpulmonarycryptococcosis can be similar to those
in PJP, ranging from diffuse inﬁltrates to solitary nodules, focal
consolidation, hilar lymphadenopathy, cavities and pleural effusion.
The rationale for treatment of isolated pulmonary cryptococ-
cosis stems from studies, which have shown that these patients are
at high risk of dissemination. Isolated pulmonary cryptococcosis
with negative cerebrospinal ﬂuid (CSF) CrAg and cultures can be
treated with azoles (ﬂuconazole) if symptoms are mild or
moderate. There are no controlled trials for management of
pulmonary cryptococcosis, but early therapy of non-CNS pulmo-
nary and extrapulmonary disease in AIDS patients reduces the risk
of progression to potentially life-threatening CNS disease. Detec-
tion of a positive sCrAg mandates a workup for dissemination
including blood cultures and lumbar puncture to exclude CNS
involvement. For disseminated cryptococcosis treatment guide-
lines lean towards treating with the same regimen as for crypto-
coccal meningitis. Based on the results of the MSG/ACTG clinical
trial, amphotericin B plus ﬂucytosine for 2 weeks, followed by
ﬂuconazole for 8e10 weeks of consolidation therapy and then life-
long maintenance therapy, is recommended as ﬁrst-line therapy.4,5
Consider stopping maintenance ﬂuconazole after 1 year of treat-
ment during anti-retroviral therapy in patients with a CD4 count
higher than 100 cells/microL, very low or undetectable HIV RNA
level, sustained for more than 3 months and Cryptococcal antigen
titer less than 1:512.5
Given the relatively non-speciﬁc clinical signs and symptoms,
variable radiographic signs, and higher incidence of other pulmo-
nary opportunistic infections such as PJP, it is likely that pulmonary
cryptococcosis is an under-diagnosed entity and not recognized
until dissemination. In an autopsy series performed on 42 AIDS
patients, an unsuspected disease was found in 18, with dissemi-
nated cryptococcal infection accounting for 28% of diagnoses (5/18).
In all those cases PJP was considered the cause of the patient’s
illness.6
Returning to our patient, he was started on empiric therapy for
PJP based on a consistent clinical picture, without establishing
a deﬁnitive diagnosis. Because of the potentially grave conse-
quences of overlooking disseminated cryptococcosis, we believe
every patient who is empirically treated for PJP should have a sCrAg
performed.
This presentation reveals the importance of considering C.
neoformans as a potential organism in patients with AIDS and
hypoxia with bilateral interstitial pulmonary inﬁltrates. Serum
cryptococcal antigen is a rapid test with very high sensitivity and
speciﬁcity, and can be used as a reliable method to exclude this
potentially fatal disease.
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